Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReliaGene Technologies was a biotechnology company specializing in forensic DNA analysis and genetic testing services. Founded in 1990 and headquartered in New Orleans, the company was a pioneer in the development and application of Y-chromosome (Y-STR) testing for human identification. ReliaGene provided critical molecular diagnostic services to law enforcement agencies, the legal community, and private individuals for criminal investigations and paternity disputes. The company operated a highly accredited laboratory and developed proprietary genetic testing kits. In 2007, ReliaGene was acquired by Orchid Cellmark, integrating its specialized forensic expertise into one of the world's largest DNA testing networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReliaGene Technologies.